308 related articles for article (PubMed ID: 18187967)
1. Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments.
Henning A; Neumann D; Kostka KH; Lehr CM; Schaefer UF
Skin Pharmacol Physiol; 2008; 21(2):81-8. PubMed ID: 18187967
[TBL] [Abstract][Full Text] [Related]
2. Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations.
Netzlaff F; Kaca M; Bock U; Haltner-Ukomadu E; Meiers P; Lehr CM; Schaefer UF
Eur J Pharm Biopharm; 2007 Apr; 66(1):127-34. PubMed ID: 17029766
[TBL] [Abstract][Full Text] [Related]
3. TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing.
Netzlaff F; Kostka KH; Lehr CM; Schaefer UF
Eur J Pharm Biopharm; 2006 May; 63(1):44-50. PubMed ID: 16380242
[TBL] [Abstract][Full Text] [Related]
4. Human skin penetration of flufenamic acid: in vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject.
Wagner H; Kostka KH; Lehr CM; Schaefer UF
J Invest Dermatol; 2002 Mar; 118(3):540-4. PubMed ID: 11874496
[TBL] [Abstract][Full Text] [Related]
5. Probing the permeation enhancement of mefenamic acid by ethanol across full-thickness skin, heat-separated epidermal membrane and heat-separated dermal membrane.
Heard CM; Screen C
Int J Pharm; 2008 Feb; 349(1-2):323-5. PubMed ID: 17870262
[TBL] [Abstract][Full Text] [Related]
6. Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents.
Wagner H; Kostka KH; Lehr CM; Schaefer UF
J Control Release; 2001 Aug; 75(3):283-95. PubMed ID: 11489316
[TBL] [Abstract][Full Text] [Related]
7. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
[TBL] [Abstract][Full Text] [Related]
8. Effects of various vehicles on the penetration of flufenamic acid into human skin.
Wagner H; Kostka KH; Adelhardt W; Schaefer UF
Eur J Pharm Biopharm; 2004 Jul; 58(1):121-9. PubMed ID: 15207545
[TBL] [Abstract][Full Text] [Related]
9. Assessment of principal parabens used in cosmetics after their passage through human epidermis-dermis layers (ex-vivo study).
El Hussein S; Muret P; Berard M; Makki S; Humbert P
Exp Dermatol; 2007 Oct; 16(10):830-6. PubMed ID: 17845215
[TBL] [Abstract][Full Text] [Related]
10. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
Zghoul N; Fuchs R; Lehr CM; Schaefer UF
ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
[TBL] [Abstract][Full Text] [Related]
11. Potential pitfalls in skin permeation experiments: influence of experimental factors and subsequent data evaluation.
Henning A; Schaefer UF; Neumann D
Eur J Pharm Biopharm; 2009 Jun; 72(2):324-31. PubMed ID: 18761087
[TBL] [Abstract][Full Text] [Related]
12. Influence of nanoencapsulation on human skin transport of flufenamic acid.
Luengo J; Weiss B; Schneider M; Ehlers A; Stracke F; König K; Kostka KH; Lehr CM; Schaefer UF
Skin Pharmacol Physiol; 2006; 19(4):190-7. PubMed ID: 16679821
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four different in vitro systems to study the reservoir capacity of the stratum corneum.
Jacobi U; Taube H; Schäfer UF; Sterry W; Lademann J
J Control Release; 2005 Mar; 103(1):61-71. PubMed ID: 15710500
[TBL] [Abstract][Full Text] [Related]
14. Drug distribution in human skin using two different in vitro test systems: comparison with in vivo data.
Wagner H; Kostka KH; Lehr CM; Schaefer UF
Pharm Res; 2000 Dec; 17(12):1475-81. PubMed ID: 11303956
[TBL] [Abstract][Full Text] [Related]
15. Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.
Mitriaikina S; Muller-Goymann CC
Skin Pharmacol Physiol; 2009; 22(3):142-50. PubMed ID: 19246962
[TBL] [Abstract][Full Text] [Related]
16. In-silico model of skin penetration based on experimentally determined input parameters. Part I: experimental determination of partition and diffusion coefficients.
Hansen S; Henning A; Naegel A; Heisig M; Wittum G; Neumann D; Kostka KH; Zbytovska J; Lehr CM; Schaefer UF
Eur J Pharm Biopharm; 2008 Feb; 68(2):352-67. PubMed ID: 17587558
[TBL] [Abstract][Full Text] [Related]
17. Permeation of bioactive constituents from Arnica montana preparations through human skin in-vitro.
Tekko IA; Bonner MC; Bowen RD; Williams AC
J Pharm Pharmacol; 2006 Sep; 58(9):1167-76. PubMed ID: 16945174
[TBL] [Abstract][Full Text] [Related]
18. Effect of selected fluorinated drugs in a "ringing" gel on rheological behaviour and skin permeation.
Höller S; Valenta C
Eur J Pharm Biopharm; 2007 Apr; 66(1):120-6. PubMed ID: 17055710
[TBL] [Abstract][Full Text] [Related]
19. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
[TBL] [Abstract][Full Text] [Related]
20. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
Panchagnula R; Desu H; Jain A; Khandavilli S
Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
